Myocarditis in children and detection of viruses in myocardial tissue: Implications for immunosuppressive therapy

Autor(es)

Camargo, Paulo Roberto ^[1] ; Okay, Thelma Suely ^[2] ; Yamamoto, Lidia ^[2] ; Barbaro Del Negro, Gilda Maria ^[2] ; Lopes, Antonio Augusto ^[1]

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Sch Med, InCor, BR-05403000 Sao Paulo - Brazil

^[2] Univ Sao Paulo, Dept Pediat, Fac Med, Lab Med Invest LIM 36, BR-05403000 Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: INTERNATIONAL JOURNAL OF CARDIOLOGY; v. 148, n. 2, p. 204-208, APR 14 2011.
• Citações Web of Science: 14

Resumo

Background: There is scarce information on the potential benefits of immunosuppression in children with myocarditis and viral genomes in myocardium. We investigated the occurrence of myocarditis in children with a preliminary diagnosis of dilated cardiomyopathy, the frequency of cardiotropic viruses in the myocardium, and the response to immunosuppression. Methods: Thirty patients (nine months to 12 years) with left ventricular ejection fraction of 22.8 +/- 4.1% were subjected to right cardiac catheterization and endomyocardial biopsy. Specimens were analyzed for the presence of inflammatory elements (Dallas criteria) and viral genome (polymerase chain reaction). Patients with active myocarditis received immunosuppressants (azatioprine and prednisone) and were recatheterized nine months later. A historical control group of nine patients with myocarditis who did not receive immunosuppressants was included. Results: Active myocarditis was diagnosed in ten patients (five with viral genomes detected). Immunosuppression resulted in a significant increase in left ventricular ejection fraction from 25.2 +/- 2.8% to 45.7 +/- 8.6% (versus 20.0 +/- 4.0% to 22.0 +/- 9.0% in historical controls, p < 0.01) and cardiac index from 3.28 +/- 0.51 L/min/m(2) to 4.40 +/- 0.49 L/min/m(2) (versus 3.50 +/- 0.40 L/min/m(2) to 3.70 +/- 0.50 L/min/m(2) in controls, p < 0.01), regardless of the presence of viral genomes (p - 0.98 and p - 0.22, respectively for the two variables). No relevant clinical events were observed. Non-inflammatory cardiomyopathy was diagnosed in 20 patients (seven with viral genomes). While on conventional therapy, there were four deaths and three assignments to transplantation, and no improvement of left ventricular ejection fraction in the remaining ones (22.5 +/- 3.6% to 27.5 +/- 10.6%). Conclusion: Children with chronic myocarditis seem to benefit from immunosuppressive therapy, regardless of the presence of viral genome in the myocardium. (C) 2009 Elsevier Ireland Ltd. All rights reserved. (AU)

• Processo FAPESP: 03/00037-0 - Impacto da presenca de genoma viral no miocardio na evolucao de criancas portadoras de miocardiopatia dilatada e miocardite.
• Beneficiário: Paulo Roberto Camargo
• Modalidade de apoio: Auxílio à Pesquisa - Regular